Pfizer court fight could legalize Medicare copays and unleash ‘gold rush’ in sales

August 19, 2021

Three years ago, pharma giant Pfizer paid $24 million to settle federal allegations that it was paying kickbacks and inflating sales by reimbursing Medicare patients for out-of-pocket medication costs. By making prohibitively expensive medicine essentially free for patients, the company induced them to use Pfizer drugs even as the price of one of those medicines, covered by Medicare and Medicaid, soared 44% to $225,000 a year, the Justice Department alleged.

Read the source article at Healthcare News
2021-07-30 19:04:14

Share This Story!